Publications by authors named "Airton Scipioni"
Adjunctive and non-pharmacological therapies, such as heat, for the treatment of heart failure patients have been proposed. Positive results have been obtained in clinically stable patients, but no studies of the use of thermal therapy in patients with decompensated heart failure (DHF) have been reported. An open randomized clinical trial was designed in patients with DHF and controls.
View Article and Find Full Text PDFBackground: Heart failure (HF) is a condition with poor outcome, especially in advanced cases. Determination of B-type natriuretic peptide (BNP) levels is useful in the diagnosis of cardiac decompensation and has also been proving useful in the prognostic evaluation.
Objectives: To verify whether BNP levels are able to identify patients with a poorer outcome and whether it is an independent prognostic factor considering age, gender, cardiac and renal functions, as well as the cause of heart disease.
Background: there is evidence that the suspension of betablockers (BB) in decompensated heart failure may increase mortality. Dobutamine (dobuta) is the most commonly used inotrope in decompensation, however, BB and dobuta act with the same receptor with antagonist actions, and concurrent use of both drugs could hinder compensation.
Objective: to evaluate whether the maintenance of BB associated with dobuta difficults cardiac compensation.
Background: Patients who require hospitalization because of decompensated HF represent a group of the most seriously ill individuals who evolve with high mortality and hospital readmission rates.
Objectives: We sought to evaluate the current natural course of HF by analyzing mortality and readmission rates in this new era of neurohormonal blockage.
Methods: We followed the progress of 263 patients with a mean EF of 27.
Background: Heart failure is a highly prevalent disease, the prognosis of which depends on different predictive factors.
Objective: Chagas disease is a predictor of poor prognosis in patients with chronic heart failure (HF). The purpose of this study is to investigate whether this condition also predicts poor outcome in acutely decompensated patients.
Objective: To verify if the determination of NT-proBNP values would help predict the prognosis in advanced heart failure (HF) patients.
Methods: One hundred and five subjects with average age of 52.4 years were evaluated, 66.
Objective: To assess whether the treatment with levosimendan is more expensive than the usual one with dobutamine, since price of medications does not usually represent the greatest expense in the treatment of cardiac decompensation.
Methods: The cost of treatment of 18 inpatients with cardiac decompensation, 9 of which treated with dobutamine (dobuta group) and 9 with levosimendan (levo group), was compared. Groups were similar concerning age, sex, functional class and cardiac function.
Objective: To study the major clinical characteristics of patients with heart failure who survived more than 24 months after hospitalization for compensation.
Methods: The study comprised 126 patients with heart failure in functional class III or IV, with a mean age of 51.7 years.